Citation Impact
9 by Nobel laureates 11 from Science/Nature 63 standout
Citing Papers
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Evaluating eligibility criteria of oncology trials using real-world data and AI
2021 StandoutNature
Works of Robert T. OʼDonnell being referenced
High-Dose Radioimmunotherapy Combined with Fixed, Low-Dose Paclitaxel in Metastatic Prostate and Breast Cancer by Using a MUC-1 Monoclonal Antibody, m170, Linked to Indium-111/Yttrium-90 via a Cathepsin Cleavable Linker with Cyclosporine to Prevent Human Anti-mouse Antibody
2005
Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment
2001
Author Peers
| Author | RNMI | PFM | Oncology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| Robert T. OʼDonnell | 1131 | 494 | 641 | 108 | 2.8k | |
| Alper Karalök | 16 | 14 | 83 | 79 | 613 | |
| Maria I. Tsiraki | 4 | 12 | 354 | |||
| Marcos Gutiérrez de la Barrera | 6 | 10 | 221 | 9 | 276 | |
| C. Andersson | 1 | 14 | 315 | |||
| Xiandi Guo | 11 | 374 |
All Works
Login with ORCID to disown or claim papers
Loading papers...